Larvol Delta - Beyond-Cancer-Announces-Approval-by-the-Israeli-Ministry-of-Health-to-Conduct-a-Phase-1b-Clinical-Trial-Utilizing-Low-Volume-UltraHigh-Concentration-Nitric-Oxide-LV-UNO-in-Combination-with-AntiPD1-Therapy

ultra-high concentration nitric oxide (UNO101) - Beyond Air

https://www.globenewswire.com/news-release/2024/12/03/2991054/0/en/Beyond-Cancer-Announces-Approval-by-the-Israeli-Ministry-of-Health-to-Conduct-a-Phase-1b-Clinical-Trial-Utilizing-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-in-Combina.html

Dec 3, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next